Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide

Stefania Terracciano, Ines Bruno, Elisabetta D'Amico, Giuseppe Bifulco, Angela Zampella, Valentina Sepe, Charles D. Smith, Raffaele Riccio

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

In the recent years, we focused our attention on the cyclodepsipeptide Jaspamide 1, an interesting marine metabolite, possessing a potent inhibitory activity against breast and prostate cancer, as a consequence of its ability to disrupt actin cytoskeleton dynamics. Although its biological profile has been well determined, many mechanistic details are still missing in terms of molecular target identification. For this reason, we decided to synthetically modify the natural metabolite, obtaining small arrays of unnatural variants useful to illuminate the structural requirements essential for the activity. Here, we report the synthesis of seven new Jaspamide analogues 2-8, containing, as the parent compound, a β-amino acid in the cyclopeptide backbone. Their biological profile is also described.

Original languageEnglish (US)
Pages (from-to)6580-6588
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number13
DOIs
StatePublished - Jul 1 2008

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide'. Together they form a unique fingerprint.

Cite this